True. While RTKs are common upstream activators, the PI3K pathway is frequently activated in cancer by direct gain-of-function mutations in the PIK3CA gene, which encodes the catalytic subunit p110α of PI3K. These mutations make PI3K constitutively active, leading to constant production of PIP3 and downstream signaling, independent of growth factor stimulation.

Break down complex topics into smaller, manageable chunks for easier recall.

Zambia

• Joseph Soko – 101 pts

• Visual Pathway Lesions
• Positive and Negative Symptoms
• Hallucinations and Delusions
• Antipsychotic Medications
• Emergency: Environmental Emergencies